Robert Castellino is an Oncology physician affiliated with Merck & Co.. OpenAlex indexes 105 publications with 2,092 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5461 Meridian Mark Rd Ste 400
Atlanta, GA 303423283
Telephone
404-785-1112Registry record last updated 6 Jun 2022.
NIH funding
1 NIH research award on record, funded 2013–2017 per NIH RePORTER. The latest:
- Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion
Emory University
FY2017$323,700R01CA172392 - Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion
Emory University
FY2016$323,700R01CA172392 - Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion
Emory University
FY2015$323,700R01CA172392
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Lubiniecki, MD
Merck & Co.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”